Medicine Description fasenra 30mg
Fasenra prefilled pen is a biologic medication that contains benralizumab. It is used for the treatment of severe
eosinophilic asthma and works by reducing episodes of breathing difficulty through targeting inflammatory cells in the
respiratory system.
It helps improve long-term asthma control and is administered by subcutaneous injection. The medication should only be
used under the supervision of a specialized physician, who determines the dosage and treatment intervals according to
the severity of the condition and the patient’s response to therapy.
Composition of Fasenra
Fasenra contains the following active ingredient:
Dosage Forms of Fasenra
The medication is available as a subcutaneous injection containing 30 mg per 1 ml and comes in a prefilled injection
pen intended for single use only.
Indications for FASENRA
The main uses of Fasenra include:
Treatment of severe eosinophilic asthma
Reducing recurrent episodes of shortness of breath
Improving lung function over the long term
Reducing dependence on corticosteroids
Controlling chronic airway inflammation
Dosage of Fasenra
The treatment is usually started with one 30 mg injection every 4 weeks. After the initial phase, the dosing interval
may be adjusted to every 8 weeks according to the patient’s response and the physician’s evaluation.
The medication is administered by subcutaneous injection only. The dose or timing should not be changed without
consulting the specialist physician to ensure safe and effective use.
Side Effects of Fasenra
The most common side effects of Fasenra include:
Contraindications of Fasenra
Fasenra should not be used in cases of severe hypersensitivity to benralizumab or any component of the medication.
Caution is advised in patients with untreated parasitic infections or unstable immune-related disorders. The
medication should only be used under the supervision of a physician specialized in treating severe asthma.
Alternatives to Fasenra in Pharmacies
Available alternatives include:
Use During Pregnancy and Breastfeeding
The medication should be used with caution during pregnancy and breastfeeding. A physician should be consulted before
starting treatment to evaluate whether it is appropriate for the patient’s condition.
It is preferable to use the medication only when medically necessary and under specialist supervision, with continuous
monitoring of the health condition of both the mother and the fetus.
The medication should not be used without direct medical supervision, and the expected benefits should always be
weighed against the potential risks before continuing treatment.
Storage Conditions
The medication should be stored under the following conditions:
Store in a refrigerator between 2°C and 8°C
Do not freeze
Keep away from direct light
Store inside the original package
Keep out of reach of children